Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Banner Left
Banner Right

Namibia not affected by cough syrup recall

Minister of health and social services Kalumbi Shangula says Benylin paediatric syrup, which has been recalled by the South African Health Products Regulatory Authority (Sahpra), is currently not registered in Namibia.

This comes after Sahpra received a report from the Nigerian National Agency for Food and Drug Administration and Control (Nafdac) regarding the detection of high levels of diethylene glycol in a batch of Benylin paediatric syrup on 10 April.

“The Namibia Medicines Regulatory Council (NMRC) confirmed with the product manufacturer, Johnson & Johnson, that no batches of Benylin paediatric syrup have been distributed to the Namibian market,” Shangula says.

He says the ministry is aware of the matter, and is continuously liaising with the NMRC secretariat to stay up to date with all developments.

Sahpra has identified the affected batch numbers as 329304 and 329303.

These batches have been distributed to South Africa (SA), Eswatini, Rwanda, Kenya, Tanzania and Nigeria.

Batch number 329304 was manufactured in SA in May 2021 and was marked with an expiry date of April 2024.

“Batch recalls are batch-specific and do not necessarily apply to other batches or similar products . . . The public is reminded that the recall is limited to two batches and should not panic regarding the range of products bearing the same name,” reads the Nafdac report.

Sahpra is alerting healthcare professionals and the public to discontinue the use of the two batches mentioned, remove them from their inventory and return them to their normal distribution channels with immediate effect.

According to the South African Government News Agency (SA News), diethylene glycol is toxic to humans when consumed and can prove fatal.

“Toxic effects can include abdominal pain, vomiting, diarrhoea, the inability to pass urine, headache, an altered mental state and acute kidney injury, which may lead to death,” says SA News.

Benylin, a red raspberry-flavoured cough syrup packed in 100ml amber bottles, is used to relieve coughs, congestion, hay fever and upper respitory allergies.

Meanwhile, drug regulators in Tanzania and Zimbabwe are the latest to have recalled the syrup as a precautionary measure, although Zimbabwe’s Medicines Control Authority says there was no record of the syrup being imported into the country.

Following Nafdac’s recall of the affected batches, Kenya’s pharmacy board ordered a halt in the sale of the syrup.

It was then followed by drug authorities in SA and Rwanda, which recalled the syrup during the weekend.

Diethylene glycol has been linked to the recent deaths of dozens of children in Cameroon and The Gambia.

Kenvue, which now owns the Benylin brand, says it is collaborating with authorities and conducting its own tests, Reuters news agency reports.

– Additional reporting BBC

Stay informed with The Namibian – your source for credible journalism. Get in-depth reporting and opinions for only N$85 a month. Invest in journalism, invest in democracy –
Subscribe Now!

Latest News